share_log

分析师:预计中药板块将于二季度迎来业绩拐点

Analyst: It is expected that the Traditional Chinese Medicine Sector will迎来 a performance turning point in the second quarter.

Breakings ·  Mar 20 18:59

On the afternoon of March 20, the General Office of the State Council issued the "Opinions on Improving the Quality of Traditional Chinese Medicine and Promoting the High-Quality Development of the Traditional Chinese Medicine Industry" (hereinafter referred to as the "Opinions"). Among them, it proposed to strengthen the protection of Traditional Chinese Medicine resources and formulate protection and development plans for Traditional Chinese Medicine resources; to develop modern seed industries for Traditional Chinese Medicine materials and to study and formulate management methods for seeds of Traditional Chinese Medicine materials. In addition, the "Opinions" also suggested focusing on innovation and specialized development, deeply exploring segmented fields, and nurturing a batch of small and medium enterprises in the Traditional Chinese Medicine field that are Specialized, Special and New. Encouragement for strategic mergers and acquisitions and resource integration, fostering leading enterprises. Policies to promote the full industry chain layout of Traditional Chinese Medicine industrial enterprises will be researched and formulated. In the secondary market, the Traditional Chinese Medicine Sector has recently fluctuated following the Large Cap market. An Analyst from a Brokerage pointed out that the Traditional Chinese Medicine Sector is expected to reach an inflection point in performance in the second quarter, and the sector's trend may initiate ahead of the performance inflection point.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment